A Study of Predictors of Renal Insufficiency Following Orthotopic Liver Transplantation

Overview

About this study

The purpose of this study is to see if certain pre-transplant markers are able to predict how the kidney will respond after a liver transplant.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adult, >18 years
  • ESLD
  • Superimposed hepatocellular carcinoma within the Milan criteria
  • Primary LTx (no repeat LTx)
  • Simultaneous liver-kidney transplant

Exclusion Criteria

  • Acute fulminant hepatic failure, status 1
  • CKD requiring dialysis > 6 months
  • Solitary kidney

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Julie Heimbach, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20307353

Mayo Clinic Footer